Quantcast
Home > Quotes > PRAN
PRAN

Prana Biotechnology Ltd American Depositary Shares (PRAN) Quote & Summary Data

$1.5
*  
0.1001
6.26%
Get PRAN Alerts
*Delayed - data as of Jan. 23, 2019 15:04 ET  -  Find a broker to begin trading PRAN now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    PRAN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 1.50 / $ 1.51
1 Year Target
4
Today's High / Low
$ 1.6441 / $ 1.48
Share Volume
32,286
50 Day Avg. Daily Volume
249,296
Previous Close
$ 1.6001
52 Week High / Low
$ 3.005 / $ 1.0854
Market Cap
13,424,376
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.07

Intraday Chart

Shares Traded

Share Volume:
32,286
50 Day Avg. Daily Volume:
249,296

Trading Range

The current last sale of $1.50 is 38.20% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 1.6441 $ 3.005
 Low: $ 1.48 $ 1.0854

Company Description (as filed with the SEC)

Our legal and commercial name is Prana Biotechnology Limited. We were incorporated under the laws of the Commonwealth of Australia on November 11, 1997 and began limited operations shortly thereafter. Our registered office is located at Level 3, 62 Lygon Street, Carlton, Victoria, 3053, Australia and our telephone number is 011-61-3-9824-5254. Our principal executive office is located at Level 3, 460 Bourke Street, Melbourne, VIC 3000, Australia and our telephone number is 011-61-3-9349-4906. Our website address is www.pranabio.com. The information in our website is not incorporated by reference into this annual report. Our mission is to develop therapeutic drugs designed to treat the underlying causes of degeneration of the brain as the aging process progresses. While we historically focused on drugs targeting Alzheimer's disease and Huntington disease, we are presently concentrating our efforts on drugs targeting Parkinsonian diseases.  ... More ...  


Risk Grade

Where does PRAN fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 1.56
Open Date:
Jan. 23, 2019
Close Price:
$ 1.60
Close Date:
Jan. 22, 2019

Consensus Recommendation

Analyst Info